GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Institutional Ownership

Biovica International AB (OSTO:BIOVIC B) Institutional Ownership : 0.29% (As of Jul. 21, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biovica International AB's institutional ownership is 0.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biovica International AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biovica International AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Biovica International AB Institutional Ownership Historical Data

The historical data trend for Biovica International AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Institutional Ownership Chart

Biovica International AB Historical Data

The historical data trend for Biovica International AB can be seen below:

2024-08-31 2024-09-30 2024-10-31 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31 2025-06-30
Institutional Ownership 0.31 0.31 0.29 0.29 0.29 0.29 0.29 0.29 0.29 0.29

Biovica International AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Biovica International AB Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines